The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV
International journal of molecular sciences · 2013 · doi:10.3390/ijms140918925 · PMID:24065096 · PMC3794814
OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher

Abstract

Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-12T06:14:43.533933+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0